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Abstract
Compaction and compression of xanthan gum pellets were evaluated and drug release from tablets made of pellets was
characterised. Two types of pellets were prepared by extrusion-spheronisation. Formulations included xanthan gum, at 16% (w/w),
diclofenac sodium or ibuprofen, at 10% (w/w), among other excipients. An amount of 500 mg of pellets fraction 1000–1400m
were compacted in a single punch press at maximum punch pressure of 125 MPa using flat-faced punches (diameter of 1.00 cm).
Physical properties of pellets and tablets were analysed. Laser profilometry analysis and scanning electron microscopy of the
upper surface and the surface of fracture of tablets revealed that particles remained as coherent individual units after compression
process. Pellets were flatted in the same direction of the applied stress evidencing a lost of the original curvature of the spherical
unit. Pellets showed close compressibility degrees (49.9% for pellets comprising diclofenac sodium and 48.5% for pellets
comprising ibuprofen). Xanthan gum pellets comprising diclofenac sodium experienced a reduction of 65.5% of their original
sphericity while those comprising ibuprofen lost 49.6% of the original porosity. Permanent deformation and densification were
the relevant mechanisms of compression. Fragmentation was regarded as non-existent. The release of the model drug from both
type of tablets revealed different behaviours. Tablets made of pellets comprising ibuprofen released the model drug in a bimodal
fashion and the release behaviour was characterised as Case II transport mechanism (release exponent of 0.93). On the other
hand, the release behaviour of diclofenac sodium from tablets made of pellets was anomalous (release exponent of 0.70). For
the latter case, drug diffusion and erosion were competing mechanisms of drug release.
© 2005 Elsevier B.V. All rights reserved.
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1. Introduction
The design and development of multiparticulate
dosage formulations in the form of tablets has been of
great interest to the pharmaceutical engineering as an
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doi:10.1016/j.ijpharm.2005.01.014
16 H. Santos et al. / International Journal of Pharmaceutics 295 (2005) 15–27
attempt to overcome the high costs involved in the pro-
duction of encapsulated dosages (C¸elik, 1994). Many
investigations evaluated the mechanisms involved dur-
ing compaction of regular and irregular shaped mul-
tiunits in order to overcome the costs involved in the
production of hard capsule dosage forms (Johansson
et al., 1995, 1998; Johansson and Alderborn, 1996,
2001; Wikberg and Alderborn, 1990a,b, 1991, 1992a,b,
1993).
It is suggested that four mechanisms are involved in
the compression process of granules namely, deforma-
tion, densification, fragmentation and attrition (C¸elik,
1994; Johansson et al., 1995). Owing to the irregular
shape and to the surface roughness of granules, it is
rather difficult to determine the degree of incidence of
the suggested mechanisms. Recently, the use of nearly
spherical units, here defined as pellets, brought new
light into the mechanistic knowledge of the compaction
process of porous particles and justified the use of these
units as an alternative model system (Johansson et al.,
1995). It has been suggested that permanent deforma-
tion and densification are the mechanisms involved in
the compression of spherical units while fragmenta-
tion and attrition seem to be inexistent or to occur to a
minute extent (Johansson et al., 1995, 1998; Johansson
and Alderborn, 1996, 2001).
The general purpose of this study was to investi-
gate the effect of the physical properties (shape, sur-
face roughness, specific surface area, tensile strength,
porosity and pore structure) of pellets on their compres-
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1995, 1998; Johansson and Alderborn, 1996, 2001) or
binary mixtures of microcrystalline cellulose and filler
(Nicklasson et al., 1999a,b). Specifically, this work in-
tended to answer whether pellets prepared by the ex-
trusion and spheronisation process and differing on the
type of one of their ingredients would differ on the
compaction behaviour, drug release and dissolution be-
haviour of the tablets.
The hydrophilic polymer xanthan gum is a high
molecular weight heteropolysaccharide gum produced
by a pure culture fermentation of a carbohydrate with
the microorganism Xanthamonas campestris. It has
been widely used in oral and topical formulations, cos-
metics and food as suspending or stabilising agent,
and release control agent in hydrophilic matrix for-
mulations (Talukdar and Plaizier-Vercammen, 1993;
Wade and Weller, 1994; Talukdar et al., 1996a,b; Ingani
and Moe¨s, 1998). Furthermore, xanthan gum proved
to have higher drug-retarding ability than the well-
known hydroxypropylmethyl cellulose (Talukdar et al.,
1996a,b; Talukdar and Kinget, 1997).
2. Materials
Diclofenac sodium (mean particle diameter
20.96m) and ibuprofen (mean particle diameter
77.97m) were purchased from Capsifar Lda, Oeiras,
Portugal and Farmachem S.A., Lugano, Switzerland,
respectively, and were used as model drugs. Xanthan
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oion behaviour and tablet forming ability (Johansson et
l., 1995, 1998; Johansson and Alderborn, 1996, 2001;
ikberg and Alderborn, 1990a,b, 1991, 1992a,b, 1993;
icklasson et al., 1999a,b). The specific purpose was to
nvestigate the influence of the physico-chemical prop-
rties of the model drug on the physical characteristics
f pellets comprising a hydrophilic polymer intended
or sustained release. For that purpose, two types of
ellets were prepared both comprising xanthan gum as
he hydrophilic polymer and one of two different active
rugs in their formulations. Pellets were also assessed
or the degree of compression and densification and
ablets made of pellets were considered for the determi-
ation of the tensile strength, total porosity, appearance
f the upper and fracture surfaces, in an attempt to add
nd/or confirm knowledge to the compression mecha-
ism of nearly spherical units formed from other mate-
ials than microcrystalline cellulose (Johansson et al.,um, purchased from Capsifar Lda, Oeiras, Portu-
al, was employed as the matrix former excipient.
icrocrystalline cellulose powder (Microcel® 101)
btained from Sagran, Milan, Italy, was the support
xcipient. Lactose monohydrate (Granulac® 200,
eggle, Wasserburg, Germany) was used as filler.
ovidone (Kolidon® K30, BASF) was employed as
secondary binder. All the materials were used as
eceived without further treatment. The granulation
iquid was a solution (50%, v/v) consisting of distilled
ater and ethanol 95% (commercial grade).
. Methods
The determination of the particle size of the active
rugs (diclofenac sodium and ibuprofen) was carried
ut in a Malvern Master Sizer (Series 2600C, Malvern
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Instruments Ltd., Malvern, UK). The mean values for
the particle diameter by volume are presented (mean
of three determinations).
Two pellets formulations were prepared. Formula-
tions were based in microcrystalline cellulose, 50%
(w/w); model drug, 10% (w/w); xanthan gum as the
control release agent, 16% (w/w); povidone as a sec-
ondary binder, 8% (w/w); and lactose monohydrate,
16% (w/w). Pellet formulation 1A (PF#1A) com-
prised diclofenac sodium, while pellet formulation 1B
(PF#1B) comprised Ibuprofen. Pellets were prepared
by extrusion-spheronisation employing ethanol/water
mixture 50% (v/v) as the binding liquid according to
previous works (Santos et al., 2002, 2004). Dry pow-
der mixtures, not including povidone, were blended in
a planetary mixer for 20 min. Povidone was included
in the formulations as a solution in the binding liq-
uid. The appropriate total quantity of the binding liq-
uid, which gave the suitable wet mass for extrusion
thus the best pellets in terms of roundness (visual in-
spection), was determined by trial and error. The wet
masses were extruded in a screen extruder (Caleva
model 10, Dorset, England) equipped with a standard
screen 1 mm diameter apertures, and rolls rotating at
60 rpm. The extrudates were transferred to the sphero-
niser (Caleva model 250, Dorset, England) equipped
with a crosshatch plate (250 mm diameter) and pro-
cessed at 1000 rpm rotating speed. The resultant pel-
lets were dried during 20 min in a fluid bed processor
(Uni-Glatt, Glatt GmbH, Binzen, Germany) with the
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and the intrusion pressure was analysed. The intrusion
pressure ranged from 0.01 to 208 MPa. The pore sizes
corresponding to the intrusion pressures were calcu-
lated assuming cylindrical pores and a surface tension
for mercury of 485 mN/m. The mercury/material ad-
vancing and receding contact angles were 130◦. The
intragranular porosity of pellets (ε) was calculated ac-
cording to Eq. (1)
ε = 1− effective pellets density
apparent pellets density
(1)
The tensile strength of pellets (σf(s)) of the different
formulations was assessed using a universal testing in-
strument equipped with a 5 kg load cell (CT-5, Engi-
neering Systems, Nottingham, UK). The pellets were
strained until failure occurred. The load was recorded
and the tensile strength was calculated applying the
values of the failure load (F) and the radius of the pel-
let (R) according to Eq. (2) (Shipway and Hutchings,
1993; Salako et al., 1998) (n= 50)
σf (s) = 0.4F
πR2
(2)
Size and shape of the pellets were concomitantly de-
rived using an image analysis system (Seescan soli-
taire 512, Seescan, Cambridge, UK) connected to a
black and white camera (CCD-4 miniature video cam-
era module, Rengo Co. Ltd., Toyohashi, Japan), zoom
lens (18-108/2.5, Olympus Co., Hamburg, Germany),
and top position cold light source (Olympus Co., Ham-
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onlet air flow at 50 ◦C. The characterisation of the pel-
ets was performed on the 1000–1400m sieve fraction
btained by dry sieving using a set of standard sieves
DIN/ISO 3310-1, Retsch, F. Kurt Retsch GmbH &
o. Haan, Germany) following a√2 progression from
00 to 2000m of sieve openings. Sieve shaker (AS
00 Control “g”, Retsch, F. Kurt Retsch GmbH & Co.,
aan, Germany) operated during 15 min with an oscil-
ation height of 1.5 mm.
The apparent particle density of the pellets was
etermined using a gas pycnometer (Multipycnome-
er, Quantachrome Co., UK) with helium as the test
as (n= 3). Porosity parameters (intrusion/extrusion
sotherms, pore size distribution, pore surface area and
ean pore diameters) and effective particle density
ere assessed using mercury porosimetry (PoreSizer
320, Micromeritics, Norcross, GA, USA) (n= 3). The
elationship between the intruded volume of mercuryurg, Germany). Feret diameter and shape factor eR
ere derived from image analysis and used for sta-
istical analysis. Shape factor eR is based on a two-
imensional outline analysis and considers both the
eometrical shape and the surface texture of the ag-
lomerate (Podczeck and Newton, 1994). For the shape
actor eR a value of unity considers a perfect spheroid
ven though a value close to 0.6 describes a particle of
ood sphericity. One hundred pellets of each formula-
ion were analysed.
Surface of pellets was analysed by applying a
on-contacting laser profilometer (UBM Microfocus
easurement System, UBM Messtechnik GmbH, Et-
lingen, Germany). The roughness parameters were
etermined using the UBSOFT software which also
rovided a three-dimensional profile of the surface
f the analysed particle. The laser spot size was
f 1m, the aperture angle 53◦, and the scanning
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speed 100 points/s. The measured area was a square
of 0.25 mm× 0.25 mm dimension with a resolution of
500 points/mm in both theX- andY-directions. The Rtm
(mean peak to valley ratio) parameter derived from the
surface roughness measurements was used for the sta-
tistical analysis. It describes the arithmetic average of
the largest height difference, each equivalent to the sum
of the largest peak and the deepest valley derived from
the line scan of a surface profile in each of 25 rectan-
gles obtained by splitting the surface into a 5× 5 grid.
This parameter provides information about the surface
that a two-dimensional line scan would not detect. Six
pellets of each formulation were analysed.
Pellets were analysed applying the BET technique
for the determination of the specific surface area us-
ing gas adsorption with nitrogen as the adsorbate gas
(ASAP 2000, Micromeritics, Norcross, USA). Deter-
mination applied the BET model to the equilibrium
isotherm within pressures of 0.05–0.30 psia. Six ex-
perimental points (BET multipoint) was used for cal-
culation. Samples were outgassed applying vacuum at
room temperature during 24 h prior to the determina-
tion of the specific surface area. Three samples of each
pellet formulation were analysed.
Unlubricated pellets were compressed using a sin-
gle punch press (Speca Press – Automatic Press, Speca
Limited, Kent, England) at maximum developed punch
pressure of 125 MPa. Press was equipped with flat-
faced punches of 1.00 cm diameter. Punches and die
were lubricated before every compaction with magne-
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density and fill weight of the pellets, and the die diam-
eter. Hp is the height of the compact. The poured bulk
density of the pellets was determined in a 250 mL glass
cylinder (inner diameter of 3.5 cm)
C% =
H0 −Hp
H0
× 100 (3)
Tablets were compressed diametrically in a material
testing machine (Erweka TBH28, Erweka Apparatebau
GmbH, Bizen, Fed. Rep. of Germany) at a compression
rate of 5 mm/min. The tensile strength of the tablets (σ)
was calculated according to Fell and Newton (1970)
(Eq. (4)) by applying the force needed to fracture the
tablet (P) and the diameter (D) and thickness (T) of
the tablet. Ten tablets of each pellet formulation were
analysed
σ = 2P
πDT
(4)
The total porosity (εTotal) of the tablets was calculated
by applying the bulk density of the compact and the ap-
parent particle density of the powder mixture. The bulk
density of the tablets was derived from the dimensions
and weight of the compacts, and the apparent particle
density of the pellets.
The upper surface of the tablets was analysed by
applying a non-contact laser profilometer (LaserScan
profilometer, Solarius Development Inc., California,
USA). The LaserScan is a surface profilometer for
3D laser measurement and was equipped with a con-
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cium stearate suspension (1% (w/w) in ethanol). An
mount of 500 mg (±0.5) sample of pellets of size
raction 1000–1400m were accurately weighed and
anually filled into the die. The prepared tablets were
tored in a diseccator at room temperature for at least
8 h before any characterisation in order to remove any
esidual humidity.
Tablets of unlubricated pellets were gently shook in
Petri dish. The deaggregated pellets obtained were
assed through a standard sieve of 1000m diame-
er apertures (DIN/ISO 3310-1, Retsch, F. Kurt Retsch
mbH & Co. Haan, Germany). The pellets retained
n the sieve (retrieved pellets) were collected and sub-
ected to characterisation.
The degree of compression of the pellets was cal-
ulated by applying Eq. (3) (Johansson and Alderborn,
996). Where, H0 is the estimated height of pellet bed
n-die before compression derived from the poured bulkocal point sensor (LT8010, LaserScan profilometer,
olarius Development Inc., California, USA) that con-
isted of a laser spot size of 2m and stand-off of
mm. The laser sensor had a measuring range of 6m,
nd vertical resolution of 0.1m. The two- and three-
imensions representations of the upper surface of the
ablets were derived by using the LaserScan software
LaserScan profilometer, Solarius Development Inc.,
alifornia, USA). The measured area of the upper
urface of the tablets was a square of approximately
.00 mm× 4.00 mm dimension.
Photomicrographs of the pellets and the upper and
racture surfaces of the tablets were taken with a
canning electron microscope (SEM) (Philips XL20,
hilips, Eindhoven, The Netherlands) for visual in-
pection of the shape and the surface texture of the
nits before and after compaction, and their mode of
ompaction.
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In vitro dissolution tests were performed according
to the USP paddle method using a dissolution appara-
tus (VK 7000 dissolution testing station, Vankel, Essex,
England). The test employed 1000 mL of phosphate
buffer pH 7.4 at 37 ◦C as the dissolution medium and
paddles rotating at 100 rpm. Sink conditions were kept
through out the test. Samples were continuously col-
lected and analysed by UV-Visible spectrophotometer
(UV-1603 Shimadzu, Shimadzu Co., Kyoto, Japan) at
277.5 nm for diclofenac sodium and 265 nm for ibupro-
fen every 15 min over 24 h. Pellets and tablets were
analysed in triplicate.
4. Results and discussion
4.1. Characterisation of pellets
Physical characteristics of the pellets comprising
either diclofenac sodium or ibuprofen as the model
drug are presented (Table 1). Both types of active pel-
lets were regarded as of good sphericity even though
they exhibited shape factor eR not higher than 0.6 but
close to this value. Such information was granted by
visual assessment (Fig. 1). The surface of the pellets
was smooth as observed in SEM micrographs never-
theless, the difference between the surface roughness
parameter derived from the laser profilometry anal-
ysis for both formulations were statistically signifi-
cant (P= 0.036, α= 0.05). Such difference could be
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).xplained in terms of the particle size of the active
ngredients. Comparatively, xanthan gum pellets com-
rising diclofenac sodium were slightly more spher-
cal, although no statistical difference between the
wo types of pellets was noticed (P= 0.341, α= 0.05),
nd displayed a less rough surface. The difference
f resistance against fracture, expressed as the ten-
ile strength, between the two types of pellets was
tatistically significant (P< 0.001, α= 0.05). Analy-
is of the pore structure of the pellets revealed that
oth types of units exhibited a sharp peak of pore
ize distribution in the range of macropores (Fig. 2).
he mean pore diameter by volume (defined as the
ore diameter at which 50% of the total volume of
ntruded mercury is intruded), which is greatly af-
ected by the number of large pores, was smaller
or pellets comprising ibuprofen. In that case, the to-
al pore volume and area were higher compared to
20 H. Santos et al. / International Journal of Pharmaceutics 295 (2005) 15–27
Fig. 1. SEM microphotographs of xanthan gum pellets at 50× magnification – (A) PF#1A; (B) cross-section of pellet PF#1A; (C) retrieved
pellet PF#1A; (D) PF#1B; (E) cross-section of pellet PF#1B; (F) retrieved pellet PF#1B. White bars denote 500m.
those presented by diclofenac sodium xanthan gum
pellets. These features indicated a great number of
small pores for xanthan gum pellets comprising ibupro-
fen.
Fig. 2. Distribution of pore diameter as a function of the differential
mercury intrusion – original pellets PF#1A (), PF#1B (), retrieved
pellets PF#1A () and PF#1B (©).
4.2. Compression of the pellets
Examination of the two- and three-dimensions rep-
resentations derived from the laser profilometry analy-
sis of the upper surface of the tablets (Figs. 3 and 4,
respectively), and the scanning electron microscopy
of the same surface including the surface of fracture
derived from the diametral compression of the tablets
(Fig. 5) revealed that the particles remained as coherent
individual units after compression process. Identifica-
tion of each pellet unit composing the tablet was clearly
observed. SEM micrographs and the 2D and 3D repre-
sentations confirmed compression-induced changes in
the shape of the units. During the process of compres-
sion the pellets were flatted in the same direction of the
applied stress evidencing a lost of the original curvature
of the spherical units. Such behaviour is in agreement
with previous observations reported in the literature
(Johansson et al., 1995, 1998; Johansson and Alder-
born, 1996, 2001; Nicklasson et al., 1999a,b; Santos et
al., 2004). The lost of sphericity was supported by the
difference in the shape factor eR for pellets before and
after compression (P< 0.001 for pellets formulation
1A and P= 0.022 for pellets formulation 1B, α= 0.05).
Such decrease in terms of shape factor was accompa-
nied by an increase of the particle diameter (Feret diam-
eter) that is a clear evidence of the shape flatness pro-
cess which pellets were submitted during compression
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Fig. 3. 2D representation of top down view of scanned area of the
upper surface of tablets made of pellets: A – tablets made of pellets
PF#1A; B – tablets made of pellets PF#1B.
(Table 1).It was also observed that a volume reduction
took place during the compression of the units. Xanthan
gum pellets comprising diclofenac sodium experienced
a porosity reduction of 65.5% while pellets compris-
ing ibuprofen reduced their porosity in approximately
49%. Compression led to the expulsion of the air en-
trapped in the cores in the form of porosity and was ac-
companied by the compaction of the units. Porosimetry
studies revealed that both types of pellets experienced
a marked reduction of the total pore volume and area
and, consequently, a decrease in terms of pore diameter
distribution (Table 2; Fig. 2). SEM micrographs of the
cross-section of both types of pellet before compression
revealed the presence of a large cavity in the centre of
the pellet (Fig. 1). Similar observation is described in
the literature (Juppo et al., 1997). The discussion of
the genesis of such cavity was not within the scope of
the present work, nevertheless its occurrence was an
indication that possibly during the compression of the
units, such cavity was diminished or even suppressed.
The extensive reduction of the porosity of the pellets
(Table 1) allied to the great reduction of the porosity
parameters (Table 2) were conclusive in determining
such observation.
The two types of pellets were considered of sta-
tistically different intragranular porosities (P< 0.001,
α= 0.05). In spite of that, no evidence of different
mechanisms of compression besides deformation and
densification was noticed. That is, fragmentation of the
pellets was regarded as minimal or non-existent. There-
fore, densification highly influenced the volume reduc-
tion of the bed of pellets after reposition and subsequent
deformation of the units.
Pellets comprising diclofenac sodium were more
porous, less susceptible to fracture and more sensi-
tive to deformation and densification compared to those
comprising ibuprofen. Comparatively, the structure of
both types of pellets displayed close degree of com-
pression although this value was slightly higher for
pellets comprising diclofenac sodium (Table 1). It is
believed that during compression, the primary parti-
cles within the pellet flowed in its structure to find new
relative positions thus being affected by the porosity of
the units. The size of the primary particle was one of
the key factors affecting the above-mentioned reposi-
tion. Diclofenac sodium was, in the present study, the
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model drug of smallest particle size thus resulting in
ellets more susceptible to reposition, of higher degree
f compression and, furthermore, of higher densifica-
ion.
.3. Compaction of pellets
Xanthan gum pellets comprising diclofenac sodium
ere of higher intragranular porosity and resulted in
ablets of tensile strength approximately four times
igher than tablets made of xanthan gum pellets com-
rising ibuprofen (Table 3). Supposedly, the higher spe-
ific surface area of pellets formulation 1A (Table 1)
as an important factor that accounted for the better de-
elopment of interparticle bonds thus being necessary
n application of higher strength to cause the break of
he tablet. The total porosity of the tablets of both for-
ulations were of close values (Table 3). It is relevant
22 H. Santos et al. / International Journal of Pharmaceutics 295 (2005) 15–27
Fig. 4. 3D representation of top down view of scanned area of the upper surface of tablets made of pellets: (A) tablets made of pellets PF#1A;
(B) tablets made of pellets PF#1B.
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Fig. 5. SEM microphotographs – (A) upper surface view of tablet
made of pellets PF#1A; (B) fracture surface view of tablet made
of pellets PF#1A; (C) upper surface view of tablet made of pellets
PF#1B; (D) fracture surface view of tablet made of pellets PF#1B.
White bars denote 500m.
Table 2
Porosity parameters of active drug xanthan gum pellets
Pellets Total pore
volume (mL/g)
Total pore
area (m2/g)
Mean pore
diameter (m)
PF#1A original 0.228 6.836 0.133
PF#1A retrieved 0.103 5.134 0.080
PF#1B original 0.241 8.881 0.109
PF#1B retrieved 0.099 6.204 0.064
to point that the compression process of pellets formu-
lation 1A, which were of higher intragranular porosity
and degree of densification, resulted in an extensive
deformation of the units followed by an extensive de-
crease in terms of porosity thus leading to compacts
of low porosity and high tensile strength. A different
behaviour was noticed for pellet formulation 1B which
were of lower intragranular porosity and degree of den-
Table 3
Physical characteristics of tablets made of drug active xanthan gum
pellets
Tablets Height (mm) Total porosity
(%)
Tensile
strength (MPa)
TF#1A 4.60 (0.005) 8.87 (0.896) 2.17 (0.167)
TF#1B 4.89 (0.006) 9.85 (1.121) 0.54 (0.088)
Mean value (standard deviation in brackets).
sification than pellet formulation 1A and resulted in
tablets of total porosity close to the former but much
more susceptible to fracture.
Tensile strength of both types of pellets implied
that pellets comprising diclofenac sodium were more
brittle and less elastic than pellets comprising ibupro-
fen. In that case, for the water-soluble model drug di-
clofenac sodium, the crystallisation of the dissolved
particles during the drying process of the wetted pel-
lets resulted in a greater degree of close interparticulate
contact hence less elastic and more brittle agglomer-
ates (Dyer et al., 1994). Nevertheless, compression of
pellets resulted in tablets of close degree of compress-
ibility although pellets formulation 1A were slightly
more susceptible to compression.
4.4. Dissolution behaviour and drug release
The release of diclofenac sodium or ibuprofen from
pellets and tablets made of xanthan gum pellets was
studied. The release of the model drugs from the two
pellets formulations was immediate, reaching the to-
tality in not more than 30 min in the case of diclofenac
sodium xanthan gum pellets while 60% of ibuprofen
was released from xanthan gum pellets after 1 h of dis-
solution test (Fig. 6). During the test the pellets ab-
sorbed water and displayed extensive swelling. Con-
comitantly, the pellets released their entire drug content
due to the disruption of the wetted/swollen structure.
Tablets made of xanthan gum pellets showed similar
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cehaviour: penetration of the medium into the core fol-
owed by swelling of the structure. The integrity of
he structure of tablets made of ibuprofen xanthan gum
ellets was kept until 3 h of dissolution test. Right after
hat time the drug was promptly released as a result
f complete disruption of the swollen structure. The
elease of diclofenac sodium from tablets made of pel-
ets was slower and approximately 70% of the drug
as released after 24 h of dissolution test. For the latter
ablets, it was observed no disintegration of the dosage
orm into the forming units. Tablets maintained their
tructure as a monolithic system resembling a swollen
ponge-like arrangement that slowed drug release over
he experimental time.
Xanthan gum, the control release agent included in
he formulations, is known to have the ability to hydrate
ery rapidly in addition to exhibit a great swelling index
ompared to other gums (Sujja-areevath et al., 1998).
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Fig. 6. Fraction of active drug released from pellets and tablets made of pellets: (©) pellets PF#1A, () pellets PF#1B, () tablets made of
pellets PF#1A, () tablets made of PF#1B.
It is speculated that drug release from tablets made
of xanthan gum pellets was a result of hydration of
the gum, which swelled extensively forming a barrier
through which drug diffused. Erosion of the tablets was
probably an important mechanism of drug release since
gradual lost of size of the swollen tablets was noticed
by visual inspection during dissolution.
As observed in a previous report (Santos et al.,
2004), the visual inspection of the tablets during disso-
lution test revealed that the swollen tablets were con-
stituted of swollen pellets on the surface that gradually
eroded and were replaced by inner swollen pellets as
the liquid medium penetrated into the core. In the case
of tablets made of pellets comprising ibuprofen, the
integrity of the swollen structure was maintained un-
til the first hour of test. During that time, the model
drug was gradually released, probably from the deag-
gregated pellets on the surface of the tablet. Soon after,
small amounts of the drug were released until com-
plete disruption of the swollen structure and consequent
complete release of ibuprofen.
Although tablets made of pellets did not act as a
multiparticulate system, the release of the model drug
was sustained over the experimental time. To elucidate
the possible release mechanism, analysis of drug re-
lease data derived from the dissolution tests were fitted
to the exponential equation (5) (Korsmeyer et al., 1983)
Mt
M∞
= ktn (5)
where Mt is the amount of drug released at time t, M∞
the nominal total amount of drug,Mt/M∞ is the fraction
of drug released within the range 0.1–0.6 at time t, k
is the kinetic constant (in t−n) that incorporates the
properties of the polymeric system and the drug, and
n is the diffusional exponent of the drug release that
is used to characterise the transport mechanism. In the
case of tablets, n= 0.45 for Case I (Fickian diffusion),
0.45 < n< 0.89 for anomalous behaviour (non-Fickian
transport) and n≥ 0.89 for Case II transport.
The release behaviour of tablets made of PF#1A
was anomalous providing release exponent (n) value
of 0.70 (R2 = 0.998). On the other hand, Case II trans-
port characterised the release behaviour of tablets made
of PF#1B (n= 0.93; R2 = 0.980). The fraction of drug
released from tablet made of pellets PF#1B is higher
than that from tablet made of pellets PF#1A since the
beginning of dissolution. The overall release rate of the
model drug from tablets TF#1B is higher than that from
tablets TF#1A. Such observation is in accordance with
the derived values of the kinetic constant k (TF#1A:
k= 0.0047; TF#1B: k= 0.0025). To confirm such ob-
servation and characterise the drug release, the mean
dissolution time (MDT) was calculated according to
Eq. (6) using the n and k values derived from Eq. (5)
(Mo¨ckel and Lippold, 1993)
MDT =
(
n
n+ 1
)
k−1/n (6)
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Fig. 7. Fraction contributions of the Fickian diffusion (©) and the erosion () mechanisms of diclofenac sodium released from tablets made of
pellets.
The MDT of tablets made of pellets including di-
clofenac sodium was approximately 14 and 5 h for
tablets made of pellets including ibuprofen.
Furthermore, to calculate the approximate contribu-
tion of the diffusional and relaxational mechanisms on
the release of the model drug diclofenac sodium, data
was fitted to the heuristic model (Eq. (7)) (Alfrey et
al., 1966; Ritger and Peppas, 1987; Peppas and Sahlin,
1989)
Mt
M∞
= k1tm + k2t2m (7)
The first term in the right-hand side of Eq. (7) refers to
the Fickian contribution while the second term is the
Case II erosional contribution. The coefficient m is the
purely Fickian diffusion exponent for a device of any
geometrical shape that exhibits controlled release. The
value ofm (0.43) for the tablets under investigation was
derived from the plot of aspect ratio of the tablets (diam-
eter/thickness) against diffusional exponent according
to Peppas and Sahlin (1989). Drug release data was fit-
ted to Eq. (7) by non-linear regression analysis using
GraphPad Prism Version 3.00 for Windows (GraphPad
Software, San Diego, CA, USA). The percentage of the
drug released due to the Fickian mechanism (Fmech)
was calculated according to Eq. (8) whereas the ratio
of relaxational (Rmech) over Fickian (Fmech) mecha-
nisms contribution was calculated according to Eq. (9)
(Peppas and Sahlin, 1989)
Fmech = 11+ (k2/k1)tm (8)
Rmech
Fmech
= k2
k1
tm (9)
The estimated contributions of the two mechanisms for
tablets made of pellets PF#1A are shown graphically
in (Fig. 7). Fickian diffusion was predominant but de-
creased after the first 3 h of dissolution while polymer
erosion gradually increased and became the predomi-
nant mechanism for the rest of dissolution time. Such
behaviour is well explained by the increase of thick-
ness of the viscous gel layer around matrix that created
a longer path length for diffusion which was followed
by polymer chain relaxation, disentanglement and ero-
sion (Sujja-areevath et al., 1996, 1998).
5. Conclusion
Laser profilometry analysis was a useful tool for the
characterisation of the mode of compaction of pellets.
The conjunction of the profilometry analysis with the
derived information from the visual inspection of the
SEM micrographs confirmed that permanent deforma-
tion of the pellets was the most relevant mechanism in-
volved in the compression of the units. Although some
incidence of fragmentation of the pellets was noticed,
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it only occurred in very little extension therefore could
be regarded as non-existent. Densification was also re-
garded as a relevant mechanism of compression since
the visual examinations and the physical analysis im-
plied its occurrence. In spite of pellets were considered
of different porosities they exhibited similar compres-
sion mechanisms. Permanent deformation and densifi-
cation of nearly spherical units were confirmed as the
most important mechanisms involved during compres-
sion process.
Disruption of the agglomerate structure was re-
ported and believed to be the result of the exces-
sive swelling of the gum at the concentration of 16%
(w/w). Pellets’ matrix integrity was destroyed in the
first hour of dissolution. Similar behaviour was noticed
for tablets of pellets comprising ibuprofen as the model
drug, matrix integrity was compromised and destroyed
after approximately 3 h of dissolution test. Such occur-
rence was possibly the result of increased total poros-
ity of the tablet due to the drug release coupled with
swelling of the gum.
Tablets of pellets comprising xanthan gum did not
function as multiparticulate system. Nevertheless drug
release control was achieved specifically in the case
of tablets made of pellets including diclofenac sodium
as the model drug. Non-Fickian transport mechanism
characterised drug release from these tablets. Tablets of
pellets including ibuprofen released the model drug in
bimodal fashion and was characterised as Fickian diffu-
sion mechanism. The approximate contribution of the
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Donoghue at Solarius Development Inc. for the laser
profilometry analysis of the tablets.
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